A Study of MK-6552 in Sleep Deprived Healthy Participants (MK-6552-003)

Clinical trial NCT06619665 · COMPLETED

Trial details

NCT number: NCT06619665
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Narcolepsy

Start date: 2024-03-19
Primary completion: 2024-07-16
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.